100% Quality Guarantee
PhD-Level Technical Support
Key Features

PE/Cyanine5 Anti-Human CD19 Antibody [HI19a] (AGEL3412)

SKU AGEL3412
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FCM
Reactivity Human
Host Species Mouse
Isotype Mouse IgG1, k
Clone HI19a
Conjugation PE/Cyanine5
$149 - $545

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

PE/Cyanine5 Anti-Human CD19 Antibody [HI19a]

The PE-Cyanine5 Anti-Human CD19 Antibody (HI19A) offered by Assay Genie is a specialized tool for researchers investigating CD19, a cell surface protein widely expressed on B cells. This antibody, optimized for use in flow cytometry applications, exhibits high specificity and sensitivity in detecting CD19 in human samples. It enables precise identification and quantification of CD19-expressing cells, making it an indispensable tool for immunology studies, particularly in the fields of cancer research and hematological disorders.CD19 is a key marker for B cell development and differentiation, playing a vital role in B cell activation and proliferation.

Targeting CD19 has proven to be a successful therapeutic strategy in the treatment of B cell malignancies, such as B cell lymphomas and leukemias. The availability of a reliable antibody like PE-Cyanine5 Anti-Human CD19 (HI19A) facilitates the exploration of CD19 biology and the development of novel immunotherapies targeting CD19-expressing cells.With validated performance and compatibility with various flow cytometry platforms, this antibody from Assay Genie enables researchers to delve deeper into the mechanisms underlying B cell-related diseases and aids in the discovery of potential therapeutic interventions targeting the CD19 protein.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose